Merit Medical Systems, Inc. (MMSI) Given Average Recommendation of “Buy” by Analysts

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have received an average recommendation of “Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $43.85.

A number of equities research analysts recently commented on the stock. BidaskClub cut shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, January 26th. Zacks Investment Research cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Thursday, January 25th. ValuEngine cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Wells Fargo & Co reaffirmed an “outperform” rating and issued a $51.00 price target (up previously from $46.00) on shares of Merit Medical Systems in a report on Thursday, November 30th. Finally, SunTrust Banks set a $47.00 target price on shares of Merit Medical Systems and gave the company a “buy” rating in a report on Thursday, November 16th.

Shares of Merit Medical Systems (NASDAQ:MMSI) opened at $45.00 on Friday. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39. The company has a market cap of $2,210.00, a P/E ratio of 75.00, a P/E/G ratio of 2.74 and a beta of 1.29. Merit Medical Systems has a 1-year low of $25.85 and a 1-year high of $48.10.

In other Merit Medical Systems news, Director Kent W. Stanger sold 2,918 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $44.55, for a total transaction of $129,996.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Franklin J. Miller sold 10,000 shares of the business’s stock in a transaction on Saturday, December 29th. The shares were sold at an average price of $43.93, for a total transaction of $439,300.00. Following the sale, the director now directly owns 21,244 shares in the company, valued at approximately $933,248.92. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock worth $1,416,379 in the last three months. Insiders own 5.00% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Merit Medical Systems by 4.5% during the 2nd quarter. Vanguard Group Inc. now owns 4,374,628 shares of the medical instruments supplier’s stock valued at $166,893,000 after purchasing an additional 187,745 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of Merit Medical Systems by 922.3% during the 2nd quarter. Janus Henderson Group PLC now owns 1,533,513 shares of the medical instruments supplier’s stock valued at $58,504,000 after purchasing an additional 1,383,513 shares in the last quarter. State Street Corp grew its position in shares of Merit Medical Systems by 9.9% during the 2nd quarter. State Street Corp now owns 1,339,547 shares of the medical instruments supplier’s stock valued at $51,105,000 after purchasing an additional 120,759 shares in the last quarter. Macquarie Group Ltd. grew its position in shares of Merit Medical Systems by 12.2% during the 2nd quarter. Macquarie Group Ltd. now owns 1,122,457 shares of the medical instruments supplier’s stock valued at $42,822,000 after purchasing an additional 122,138 shares in the last quarter. Finally, Rockefeller Financial Services Inc. grew its position in shares of Merit Medical Systems by 4.6% during the 4th quarter. Rockefeller Financial Services Inc. now owns 781,227 shares of the medical instruments supplier’s stock valued at $33,749,000 after purchasing an additional 34,175 shares in the last quarter. Hedge funds and other institutional investors own 88.03% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/04/merit-medical-systems-inc-mmsi-given-average-recommendation-of-buy-by-analysts.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply